Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shin-ichiro Kubo

Showing results (1-10 of 44) with videos related to

Pageof 5
Sort By:
Expert Opinion on Therapeutic Targets|November 27, 2015
Membrane lipids as therapeutic targets for Parkinson's disease: a possible link between Lewy pathology and membrane lipidsShin-Ichiro Kubo
Rinsho Shinkeigaku = Clinical Neurology|January 24, 2008
[The pathogenesis of Parkinson's disease: a hint from insights of familial Parkinson's disease]Nobutaka Hattori, Shin-ichiro Kubo
Frontiers in Bioscience (Landmark Edition)|January 2, 2015
Lipid rafts involvement in the pathogenesis of Parkinson's diseaseShin-ichiro Kubo, Taku Hatano, Nobutaka Hattori
Movement Disorders : Official Journal of the Movement Disorder Society|April 15, 2006
Recessive Parkinson's diseaseShin-ichiro Kubo, Nobutaka Hattori, Yoshikuni Mizuno
Journal of Neurochemistry|September 29, 2009
Pathogenesis of familial Parkinson's disease: new insights based on monogenic forms of Parkinson's diseaseTaku Hatano, Shin-ichiro Kubo, Shigeto Sato, et al.
Eneurologicalsci|May 23, 2024
The effects of lactulose on constipation in patients with Parkinson's disease: An exploratory pilot studyShin-Ichiro Kubo, Mako Ito, Kyoko Matsuba, et al.
Expert Opinion on Therapeutic Targets|August 13, 2013
Can parkin be a target for future treatment of Parkinson's disease?Shin-Ichiro Kubo, Taku Hatano, Masashi Takanashi, et al.
Parkinsonism & Related Disorders|May 19, 2007
Visual impairment in Parkinson's disease treated with amantadine: case report and review of the literatureShin-ichiro Kubo, Akira Iwatake, Nobuyuki Ebihara, et al.
Clinical Parkinsonism & Related Disorders|July 28, 2021
What can we learn from the effect of trihexyphenidyl on motor fluctuations during continuous levodopa-carbidopa intestinal gel infusion (LCIG)? - First documented caseShin-Ichiro Kubo, Ken Nakamura, Yoshimasa Tada, et al.
Psychogeriatrics : the Official Journal of the Japanese Psychogeriatric Society|March 26, 2014
Effects of donepezil dose escalation in Parkinson's patients with dementia receiving long-term donepezil treatment: an exploratory studyKei-Ichi Ishikawa, Yumiko Motoi, Yoshikuni Mizuno, et al.
Pageof 5

Showing results (1-10 of 44) with videos related to

Sort By:
Pageof 5
Expert Opinion on Therapeutic Targets|November 27, 2015
Membrane lipids as therapeutic targets for Parkinson's disease: a possible link between Lewy pathology and membrane lipidsShin-Ichiro Kubo
Rinsho Shinkeigaku = Clinical Neurology|January 24, 2008
[The pathogenesis of Parkinson's disease: a hint from insights of familial Parkinson's disease]Nobutaka Hattori, Shin-ichiro Kubo
Frontiers in Bioscience (Landmark Edition)|January 2, 2015
Lipid rafts involvement in the pathogenesis of Parkinson's diseaseShin-ichiro Kubo, Taku Hatano, Nobutaka Hattori
Movement Disorders : Official Journal of the Movement Disorder Society|April 15, 2006
Recessive Parkinson's diseaseShin-ichiro Kubo, Nobutaka Hattori, Yoshikuni Mizuno
Journal of Neurochemistry|September 29, 2009
Pathogenesis of familial Parkinson's disease: new insights based on monogenic forms of Parkinson's diseaseTaku Hatano, Shin-ichiro Kubo, Shigeto Sato, et al.
Eneurologicalsci|May 23, 2024
The effects of lactulose on constipation in patients with Parkinson's disease: An exploratory pilot studyShin-Ichiro Kubo, Mako Ito, Kyoko Matsuba, et al.
Expert Opinion on Therapeutic Targets|August 13, 2013
Can parkin be a target for future treatment of Parkinson's disease?Shin-Ichiro Kubo, Taku Hatano, Masashi Takanashi, et al.
Parkinsonism & Related Disorders|May 19, 2007
Visual impairment in Parkinson's disease treated with amantadine: case report and review of the literatureShin-ichiro Kubo, Akira Iwatake, Nobuyuki Ebihara, et al.
Clinical Parkinsonism & Related Disorders|July 28, 2021
What can we learn from the effect of trihexyphenidyl on motor fluctuations during continuous levodopa-carbidopa intestinal gel infusion (LCIG)? - First documented caseShin-Ichiro Kubo, Ken Nakamura, Yoshimasa Tada, et al.
Psychogeriatrics : the Official Journal of the Japanese Psychogeriatric Society|March 26, 2014
Effects of donepezil dose escalation in Parkinson's patients with dementia receiving long-term donepezil treatment: an exploratory studyKei-Ichi Ishikawa, Yumiko Motoi, Yoshikuni Mizuno, et al.
Pageof 5